The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release.

What Are the Types of Health Insurance Plans? Health insurance companies offer multiple types of benefit designs, which affect where you can get care, how much you’ll pay and whether you need a ...

ACELYRIN, Inc., a Los Angeles area-based, late-stage clinical biopharma, with additional operations in the San Francisco Bay area, has announced it is acquiring privately held ValenzaBio – which ...